Wilshire Pharmaceuticals is associated with dextroamphetamine formulations. Specifically, Wilshire has marketed and distributed dextroamphetamine sulfate tablets [1].
What other dextroamphetamine products are available?
Dextroamphetamine is available in various forms and under different brand names. Common formulations include immediate-release tablets, extended-release capsules, and oral solutions. These medications are prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy [2].
When does Wilshire's dextroamphetamine patent expire?
Information regarding specific patent expiry dates for Wilshire's dextroamphetamine products is not readily available in the provided context. However, for general patent information on pharmaceutical products, resources like DrugPatentWatch.com can be consulted [3].
Who manufactures dextroamphetamine?
Several pharmaceutical companies manufacture dextroamphetamine. Besides Wilshire Pharmaceuticals, other manufacturers include Lannett Company, Inc., and Amneal Pharmaceuticals LLC, which have also been involved in the production and distribution of dextroamphetamine sulfate tablets [1].
What is dextroamphetamine used for?
Dextroamphetamine is a central nervous system stimulant primarily used to manage symptoms of attention deficit hyperactivity disorder (ADHD) in both children and adults. It helps improve focus, attention, and impulse control. Additionally, it is prescribed to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness [2].